World Health Organization– tag –
-
Dexcom G7 15-Day Continuous Glucose Monitor Authorized by Health Canada, Stelo CGM Cleared for Pediatric OTC Use by U.S. FDA
Business Wire, MarketScreener, CureCapture, Oura Member Care USA, Canada Overview Dexcom's G7 15-day continuous glucose monitoring (CGM) system has received Health Canada authorization for adults aged 18 and older, extending wear time to... -
Cohort Study Confirms Primary Care-Initiated Continuous Glucose Monitoring Significantly Improves HbA1c and Reduces Hospitalizations in Insulin-Treated Diabetics
JAMA Network Open USA Overview A new cohort study published in JAMA Network Open demonstrates that initiating Continuous Glucose Monitoring (CGM) in insulin-treated adults with diabetes through primary care clinicians leads to clinically... -
FDA Clears Dexcom Stelo Glucose Biosensor as First Over-the-Counter CGM for Insulin-Naive Children Aged 2 and Up
U.S. Food and Drug Administration (FDA) USA Overview The U.S. FDA has granted the first over-the-counter (OTC) clearance for Dexcom's Stelo Glucose Biosensor System, expanding its use to insulin-naive children aged two and older. This la... -
University of Twente Announces Biosensor Chip for Highly Sensitive Cervical Cancer Detection via Urine Samples: Aims to Replace Smear Tests within 5-10 Years
University of Twente Netherlands Overview Professor Loes Segerink at the University of Twente is developing a biosensor chip for easier cervical cancer detection. This technology aims to replace traditional smear tests within 5–10 years ... -
GoodRx Compares Leading CGMs: Dexcom G7 10-Day Sensor Emerges as Sole FDA-Approved Device for Children Ages 2+
GoodRx USA Overview According to a GoodRx comparison report, the Dexcom G7 10-day sensor is FDA-approved for adults and children aged 2 and older, while the Dexcom G7 15-day sensor and Eversense 365 are approved exclusively for adults ag... -
CRP Point-of-Care Testing (POCT) Significantly Reduces Pediatric Antibiotic Prescriptions by 20-30%
Aidian フィンランド Overview New findings from two large-scale randomized controlled trials (COORDINATE and ARON) demonstrate that C-reactive protein (CRP) Point-of-Care Testing (POCT) can safely and effectively guide antibiotic use in c... -
FDA Clears Dexcom Stelo as First OTC Continuous Glucose Monitor for Non-Insulin-Using Children (Ages 2+)
HCPLive USA Overview The FDA has approved Dexcom's Stelo Glucose Biosensor System for over-the-counter (OTC) use in children aged 2 years and older who do not use insulin. This marks Stelo as the first OTC continuous glucose monitoring (... -
Abbott’s FreeStyle Libre Offers 10-Day Real-Time Glucose Monitoring for Diabetes Patients Aged 4 and Up
Health Insider Canada Overview Abbott Laboratories' FreeStyle Libre system provides continuous glucose monitoring for diabetes patients aged four and older, utilizing a small wearable sensor and a smartphone app. This system delivers rea... -
Senseonics Presents Eversense 365 Real-World Data at ADA Scientific Sessions, Highlights 180-Day Wear for Unmet CGM Needs
Peninsula Fly Fishers USA Overview Senseonics Holdings presented real-world evidence for its Eversense 365 implantable continuous glucose monitoring (CGM) system during the American Diabetes Association (ADA)'s 86th Scientific Sessions. ... -
Ultrahuman Launches M2 Live Metabolic Health Platform in U.S., Integrating Abbott’s OTC Lingo CGM for Prescription-Free Glucose Tracking
PR Newswire USA Overview Ultrahuman, a smart ring manufacturer, has launched 'M2 Live,' a metabolic health platform in the U.S. that integrates data from Abbott's over-the-counter (OTC) continuous glucose monitor (CGM) 'Lingo.' Available...
